Trials / Unknown
UnknownNCT00524823
Early Detection of Prostate Cancer by FACS
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Ziv Hospital · Other Government
- Sex
- Male
- Age
- 60 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
Early detection of prostrate cancer and development of metastases. The research will attempt to match the SCM test (structuredness of the cytoplasmic matrix) in lymphocytes as an early cancer detection test using Florescent Activated Cell Sorting (FACS) as a replacement for the CellScan instrument. The test is based on measurement of cellular changes in response to the specific prostate antigen, PSA.
Conditions
Timeline
- Start date
- 2007-08-01
- First posted
- 2007-09-05
- Last updated
- 2007-09-05
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00524823. Inclusion in this directory is not an endorsement.